"10.1371_journal.pone.0104257","plos one","2014-08-21T00:00:00Z","Jost Langhorst; Annika Frede; Markus Knott; Eva Pastille; Jan Buer; Gustav J Dobos; Astrid M Westendorf","Department for Integrative Gastroenterology, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany; Department for Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany; Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany","Wrote the paper: JL MK AMW. Contributed to conception and design of the study: JL MK JB GD AMW. Contributed to acquisition of data: JL GD. Contributed to analysis and interpretation of data: AF MK EP JB AMW. Performed the data analysis: AF MK EP.","The authors have the following interests. J. Langhorst has served as a speaker for Repha GmbH, Techlab Inc, Falk Foundation and received research funding from Techlab Inc., M. Knott: Nothing to declare, A. Frede: Nothing to declare, E. Pastille: Nothing to declare, J. Buer: Nothing to declare, G. Dobos has served as a speaker for Schwabe GmbH, Roche GmbH and received research funding from Schwabe GmbH, A. Westendorf: Nothing to declare. This study was performed as an independent sub-study of a drug trial comparing the efficacy of a herbal preparation of myrrh, dry extract of chamomile flowers and coffee charcoal to mesalamine as treatment for maintaining remission in ulcerative colitis which was funded in full by REPHA GmbH Biologische Arzneimittel, Hannover, Germany. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","08","Jost Langhorst","JL",7,TRUE,NA,3,NA,3,TRUE,FALSE,FALSE,0,NA,FALSE
